These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients. Tandon R; Mann NA; Eisner WH; Coppard N Psychiatry Res; 1990 Mar; 31(3):235-41. PubMed ID: 2333355 [TBL] [Abstract][Full Text] [Related]
63. Neuroleptic-withdrawal cachexia. Mikkelsen EJ; Albert LG; Upadhyaya A N Engl J Med; 1988 Apr; 318(14):929. PubMed ID: 2895425 [No Abstract] [Full Text] [Related]
64. Neuroleptics and depression. Wistedt B Arch Gen Psychiatry; 1982 Jun; 39(6):745. PubMed ID: 6124226 [No Abstract] [Full Text] [Related]
65. A case of auto-erotic asphyxia in a long-term psychiatric setting. Quinn J; Twomey P Psychopathology; 1998; 31(4):169-73. PubMed ID: 9697159 [TBL] [Abstract][Full Text] [Related]
66. The need for long-term neuroleptic treatment in schizophrenia. Dencker SJ Acta Psychiatr Scand Suppl; 1981; 291():29-43. PubMed ID: 6113733 [TBL] [Abstract][Full Text] [Related]
67. Psychotic symptoms following oxycodone withdrawal, case report and update. Casado-Espada NM; Martín C; De La Iglesia-Larrad JI; De Alarcón R; Fombellida CI; Fernández-Martín LC; Roncero C Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6315-6320. PubMed ID: 31364138 [TBL] [Abstract][Full Text] [Related]
69. Attentional and clinical neuroleptic response in schizophrenia: a study with the continuous performance test. Serper MR; Harvey PD; Davidson M Cogn Neuropsychiatry; 1997 Nov; 2(4):241-9. PubMed ID: 25419792 [TBL] [Abstract][Full Text] [Related]
70. The mechanism of neuroleptic withdrawal. Eppel AB; Mishra R Can J Psychiatry; 1984 Oct; 29(6):508-9. PubMed ID: 6149010 [TBL] [Abstract][Full Text] [Related]
71. Neuroleptic-induced psychotic deterioration in a schizophrenic. Gershon S J Clin Psychopharmacol; 1981 Mar; 1(2):96. PubMed ID: 6117581 [No Abstract] [Full Text] [Related]
72. Object-name selection in psychiatric patients before and after neuroleptic therapy. Calvert JE; Babiker IE; Harris JP; Phillipson OT; Ford MF; Antebi DL J Psychopharmacol; 1990 Jan; 4(2):75-82. PubMed ID: 22282931 [TBL] [Abstract][Full Text] [Related]
73. Saliva secretion disorder in a schizophrenic patient - a problem in dental and psychiatric treatment: a case report. Moś DM Ann Gen Psychiatry; 2015; 14():14. PubMed ID: 25810747 [TBL] [Abstract][Full Text] [Related]
74. Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients. Grinshpoon A; Moskowitz M; Valevski A; Kreizman A; Palei L; Mar M; Weizman A Eur Psychiatry; 1998 Aug; 13(5):273-5. PubMed ID: 19698639 [TBL] [Abstract][Full Text] [Related]
76. Reactions to novel and familiar stimuli as a function of schizophrenic withdrawal. MCREYNOLDS P Percept Mot Skills; 1963 Jun; 16():847-50. PubMed ID: 13932278 [No Abstract] [Full Text] [Related]